NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• Trump: Iran Will Pay For US Forces Killings Many Times Over
• H.B. Fuller refinances credit facilities, extends maturity to 2031
• Iran missile struck housing for U.S. troops at Jordan base - WSJ